Japan approves its first Alzheimer’s drug
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and US pharmaceutical companies.
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and US pharmaceutical companies.